Latent antigen vaccination in a model gammaherpesvirus infection.

Usherwood, E J; Ward, K A; Blackman, M A; Stewart, J P; Woodland, D L

Usherwood, E J; Ward, K A; Blackman, M A; Stewart, J P; Woodland, D L.

Affiliation

Usherwood EJ; The Trudeau Institute, Saranac Lake, New York 12983, USA.

J Virol ; 75(17): 8283-8, 2001 Sep.

Article in En | MEDLINE | ID: mdl-11483773

Subject(s)

Gammaherpesvirinae/immunology; Gammaherpesvirinae/physiology; Herpesviridae Infections/virology; Viral Matrix Proteins/immunology; Viral Vaccines/immunology; Virus Latency/immunology; Animals; Antigens, Viral/genetics; Antigens, Viral/immunology; Antigens, Viral/metabolism; CD8-Positive T-Lymphocytes/immunology; Disease Models, Animal; Epitopes, T-Lymphocyte/immunology; Gammaherpesvirinae/genetics; H-2 Antigens/immunology; Herpesviridae Infections/immunology; Herpesviridae Infections/prevention & control; Humans; Lung/virology; Mice; Mice, Inbred BALB C; Vaccination; Vaccines, DNA/administration & dosage; Vaccines, DNA/immunology; Viral Matrix Proteins/genetics; Viral Matrix Proteins/metabolism; Viral Vaccines/administration & dosage

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Viral Vaccines / Viral Matrix Proteins / Virus Latency / Gammaherpesvirinae / Herpesviridae Infections Limits: Animals / Humans Language: En Journal: J Virol Year: 2001 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google